94 related articles for article (PubMed ID: 38674418)
21. A Prognostic Signature for Lower Grade Gliomas Based on Expression of Long Non-Coding RNAs.
Kiran M; Chatrath A; Tang X; Keenan DM; Dutta A
Mol Neurobiol; 2019 Jul; 56(7):4786-4798. PubMed ID: 30392137
[TBL] [Abstract][Full Text] [Related]
22. Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities.
Linares CA; Varghese A; Ghose A; Shinde SD; Adeleke S; Sanchez E; Sheriff M; Chargari C; Rassy E; Boussios S
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686020
[TBL] [Abstract][Full Text] [Related]
23. Identification of immune-related lncRNA in sepsis by construction of ceRNA network and integrating bioinformatic analysis.
Wang T; Xu S; Zhang L; Yang T; Fan X; Zhu C; Wang Y; Tong F; Mei Q; Pan A
BMC Genomics; 2023 Aug; 24(1):484. PubMed ID: 37620751
[TBL] [Abstract][Full Text] [Related]
24. An Angiogenesis-Related lncRNA Signature Is Associated with Prognosis and Tumor Immune Microenvironment in Breast Cancer.
Gao S; Wang Y; Xu Y; Liu S
J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983695
[TBL] [Abstract][Full Text] [Related]
25. Identification of a copper metabolism-related gene signature for predicting prognosis and immune response in glioma.
Li L; Leng W; Chen J; Li S; Lei B; Zhang H; Zhao H
Cancer Med; 2023 Apr; 12(8):10123-10137. PubMed ID: 36856182
[TBL] [Abstract][Full Text] [Related]
26. Targeting the LINC00324/miR-16-5p/SEPT2 Signaling Cascade is Effective to Reverse Malignant Phenotypes in Glioblastoma.
Chen B; Lin P; Li N
Anticancer Agents Med Chem; 2023; 23(13):1535-1544. PubMed ID: 36852794
[TBL] [Abstract][Full Text] [Related]
27. MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII.
Tong F; Zhao JX; Fang ZY; Cui XT; Su DY; Liu X; Zhou JH; Wang GX; Qiu ZJ; Liu SZ; Fu JQ; Kang CS; Wang JC; Wang QX
Pharmacol Res; 2023 Jan; 187():106606. PubMed ID: 36516884
[TBL] [Abstract][Full Text] [Related]
28. Current understanding of gliomagenesis: from model to mechanism.
Luo J; Junaid M; Hamid N; Duan JJ; Yang X; Pei DS
Int J Med Sci; 2022; 19(14):2071-2079. PubMed ID: 36483593
[TBL] [Abstract][Full Text] [Related]
29. A novel prognostic signature based on N7-methylguanosine-related long non-coding RNAs in breast cancer.
Huang Z; Lou K; Liu H
Front Genet; 2022; 13():1030275. PubMed ID: 36313442
[TBL] [Abstract][Full Text] [Related]
30. Structural insights into the functional roles of 14-3-3 proteins.
Obsilova V; Obsil T
Front Mol Biosci; 2022; 9():1016071. PubMed ID: 36188227
[TBL] [Abstract][Full Text] [Related]
31. Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma.
Wu H; Wei M; Li Y; Ma Q; Zhang H
Front Mol Neurosci; 2022; 15():910543. PubMed ID: 35935338
[TBL] [Abstract][Full Text] [Related]
32. A Targeted Next-Generation Sequencing Panel to Genotype Gliomas.
Guarnaccia M; Guarnaccia L; La Cognata V; Navone SE; Campanella R; Ampollini A; Locatelli M; Miozzo M; Marfia G; Cavallaro S
Life (Basel); 2022 Jun; 12(7):. PubMed ID: 35888045
[TBL] [Abstract][Full Text] [Related]
33. Expression and Prognostic Role of Glia Maturation Factor-γ in Gliomas.
Liu J; Zhu X; Gao L; Geng R; Tao X; Xu H; Chen Z
Front Mol Neurosci; 2022; 15():906762. PubMed ID: 35845613
[TBL] [Abstract][Full Text] [Related]
34. Necroptosis-Associated lncRNA Prognostic Model and Clustering Analysis: Prognosis Prediction and Tumor-Infiltrating Lymphocytes in Breast Cancer.
Tao S; Tao K; Cai X
J Oncol; 2022; 2022():7099930. PubMed ID: 35528236
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNAs as promising biomarkers in cancer.
Beylerli O; Gareev I; Sufianov A; Ilyasova T; Guang Y
Noncoding RNA Res; 2022 Jun; 7(2):66-70. PubMed ID: 35310927
[TBL] [Abstract][Full Text] [Related]
36. High myosin binding protein H expression predicts poor prognosis in glioma patients.
Zhang J; Guo Q; Zhang G; Cao X; Chen W; Li Y; Guan M; Yu J; Wang X; Yan Y
Sci Rep; 2022 Jan; 12(1):1525. PubMed ID: 35087137
[TBL] [Abstract][Full Text] [Related]
37. Glioma: molecular signature and crossroads with tumor microenvironment.
Barthel L; Hadamitzky M; Dammann P; Schedlowski M; Sure U; Thakur BK; Hetze S
Cancer Metastasis Rev; 2022 Mar; 41(1):53-75. PubMed ID: 34687436
[TBL] [Abstract][Full Text] [Related]
38. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.
Wu T; Hu E; Xu S; Chen M; Guo P; Dai Z; Feng T; Zhou L; Tang W; Zhan L; Fu X; Liu S; Bo X; Yu G
Innovation (Camb); 2021 Aug; 2(3):100141. PubMed ID: 34557778
[TBL] [Abstract][Full Text] [Related]
39. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Wesseling P; Brat DJ; Cree IA; Figarella-Branger D; Hawkins C; Ng HK; Pfister SM; Reifenberger G; Soffietti R; von Deimling A; Ellison DW
Neuro Oncol; 2021 Aug; 23(8):1231-1251. PubMed ID: 34185076
[TBL] [Abstract][Full Text] [Related]
40. S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma.
Zhang Y; Yang X; Zhu XL; Bai H; Wang ZZ; Zhang JJ; Hao CY; Duan HB
Aging (Albany NY); 2021 Jun; 13(11):15459-15478. PubMed ID: 34148033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
